E89R
TEAS SECTION 8 & 9 RECEIVED
06/26/2026
Back to search
Official data from USPTO
YOSEMITE PATHOLOGY QUALITY DIAGNOSTICS FOR OPTIMUM PATIENT CARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
06/26/2026
Trademark type
Combined
Nice classes
42, 44
Filing date
06/08/2016
Registration date
04/04/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/19/2022
Last transaction
06/26/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
04/30/2016
First use in commerce
04/30/2016
Drawing code
3
Owner type
03
Owner location
Modesto, CA, US
Examiner
ADEMI, XHENETA
Law office
N40
Current location
TMO LAW OFFICE 122
Mark description
The mark consists of a substantially circular scattershot grouping of substantially circularly shaped dots of various diameters, followed by the wording "YOSEMITE PATHOLOGY" under which appears the wording "QUALITY DIAGNOSTICS FOR OPTIMUM PATIENT CARE".
Holders and representatives
Holders
Yosemite Pathology Medical Group, Inc.
Representatives
Rob G. Leach CHARMASSON, BUCHACA & LEACH, LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Laboratory analysis in the field of pathology; Medical laboratory services
Class 44
Medical services; Medical services in the field of pathology
Publications
History of USPTO decisions and trademark events.
24 publications found
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/04/2026
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/19/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/19/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/19/2022
E815
TEAS SECTION 8 & 15 RECEIVED
05/13/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/04/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
04/04/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/17/2017
PUBO
PUBLISHED FOR OPPOSITION
01/17/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/28/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/12/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/23/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/21/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/21/2016
ALIE
ASSIGNED TO LIE
11/08/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/27/2016
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
09/22/2016
GPRA
PRIORITY ACTION E-MAILED
09/22/2016
CPRA
PRIORITY ACTION WRITTEN
09/22/2016
DOCK
ASSIGNED TO EXAMINER
09/19/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/16/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/15/2016
NWAP
NEW APPLICATION ENTERED
06/11/2016
Continuous trademark protection
Get notified about every new filing that threatens YOSEMITE PATHOLOGY QUALITY DIAGNOSTICS FOR OPTIMUM PATIENT CARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.